Datopotamab,Pembrolizumab
Merck,Daiichi Sankyo,AstraZeneca
['pembro', 'tropion,lung02', 'datopotamab', 'rux,(-crux),(-trux)', 'sclc', 'lung', 'tropion,lung,02', 'lcsm,(-blcsm)', 'nsclc', 'tropion,lung,2']
1st line results from the tropion-lung02 study of an antibody conjugate drug (datopotamab deruxtecan) plus immunotherapy (pembro) +/- platinum chemo in advanced #nsclc presented by dr. yasushi goto. mild aes to be managed, promising with additional studies ongoing. #asco23 #lcsm 
LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.